2021
DOI: 10.14309/01.ajg.0000777604.13707.27
|View full text |Cite
|
Sign up to set email alerts
|

S1018 Rectal NSAIDs Decrease Post-ERCP Pancreatitis (PEP) in Unselected Patients - Comprehensive Meta-Analysis of Randomized Controlled Trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“… 26 , 27 Protective factors include use of rectal non-steroidal anti-inflammatory drugs (NSAIDs). 28 Other complications associated with ERCP include post-ERCP cholangitis (PEC), perforation, hemorrhage, cardiopulmonary complications, and mortality. 7 …”
Section: Introductionmentioning
confidence: 99%
“… 26 , 27 Protective factors include use of rectal non-steroidal anti-inflammatory drugs (NSAIDs). 28 Other complications associated with ERCP include post-ERCP cholangitis (PEC), perforation, hemorrhage, cardiopulmonary complications, and mortality. 7 …”
Section: Introductionmentioning
confidence: 99%